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P otassium salts are currently used for the treatment of digitalis intoxication, 
and in heart failure, especially where hypo- 
kalemia has occurred after the aggressive 
use of diuretics. They are also used pro- 
phylactically to prevent losses of potassium 
during the long-term administration of 
thiazide diuretics. A few patients with myo- 
cardial infarction and coronary artery 
disease have received potassium along with 
glucose and insulin .l In order to help find 
the proper place for potassium in the treat- 
ment of heart disease, I have undertaken 
to review what is known in this field, in the 
hope that this might suggest where future 
research would be rewarding, and possibly 
to forestall unwarranted enthusiasm for any 
general application of potassium therapy. 
Abnormal distribution of potassium in 
heart disease. Over the past three decades 
evidence has accumulated showing that 
cardiac and skeletal muscle of patients 
dying of congestive failure is abnormally 
poor in potassium, phosphorous, and mag- 
nesium, and that sodium tends to be in- 
creased.“-7 Calhoun and associates4 further 
noted that potassium deficiency could be 
present in one ventricle but not in the 
other. When myocardial insufficiency re- 
sulted in pulmonary congestion, the po- 
tassium content of the left ventricle was 
diminished; and when myocardial insuf- 
ficiency resulted in hepatic congestion 
and systemic edema, the potassium content 
of the right ventricle was decreased. They 
attributed the loss of potassium to over- 
work of the involved ventricle, noting 
that overworked skeletal muscle becomes 
deficient in potassium. Factors which 
would contribute to the diffusion of po- 
tassium from heart muscle in these circum- 
stances are the associated lack of oxygen 
and the increased concentration of hydro- 
gen ion. 
Brown, Tanner and HechP have ob- 
served that patients with heart disease 
have a delayed excretion and a positive 
balance of orally administered potassium. 
They thought that potassium should be 
used with care in patients with heart dis- 
ease, since these patients do not excrete 
potassium as rapidly as do normal patients. 
Digitalis and loss of potassium. Calhoun 
and Harrison” were first to recognize that 
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toxic doses of digitalis lowered the potas- 
sium content of ventricular muscle. This 
fact has now been confirmed by many 
investigators. Until recently, there was 
controversy whether therapeutic doses of 
digitalis caused an ingress of potassium 
into the heart or egress of it from the 
heart. Most investigators now concede 
that therapeutic doses of digitalis produce 
a small net gain in potassium by cardiac 
muscle, and that large and toxic doses 
produce a larger net Ioss.~-~~ The amount 
of potassium lost from cardiac muscle in- 
creases with the dose of digitalis glycoside, 
and ConnIb has suggested that one action 
of digitalis is inhibition of an influx mech- 
anism of potassium. It has also been ob- 
served that the loss of potassium which 
occurs after the administration of large 
or toxic doses of digitalis could be inhibited 
by the administration of excess potassium.13 
These ideas have important therapeutic 
implications. It is obviously desirable to 
reverse by the administration of potas- 
sium the losses of cardiac potassium pro- 
duced by toxic doses of digitalis. However, 
the hazard of producing potassium intoxi- 
cation in this circumstance may be great, 
since less of the circulating potassium is 
free to enter the cellular compartment. 
For instance, Fisch and associateszO have 
shown in experimental animals that the 
tolerance for intravenously administered 
potassium is related to the quantity of 
digitoxin administered prior to the injec- 
tion of potassium. When potassium was 
administered to animals which had re- 
ceived an intoxicating dose of digitoxin, 
relatively small amounts of potassium 
caused a rapid rise in the plasma level of 
such a magnitude as to result in early 
cardiac standstill ; whereas animals re- 
ceiving only therapeutic amounts of digi- 
toxin tolerated higher doses of potassium, 
with resultant lower levels of plasma po- 
tassium and fewer side effects. These data 
confirm the concept that large doses of 
digitalis block the entry of potassium into 
cells, but also make it evident that the 
threat to the organism is elevation of the 
level of extracellular potassium and not 
the total dose of potassium administered. 
The data also make clear the potential 
danger of administering potassium to fully 
digitalized patients with normal serum 
potassium; for in this instance the serum 
potassium may rise to high levels, produc- 
ing potassium intoxication. 
Potassium therapy in digitalis intoxica- 
tion. Interest in the prevention and treat- 
ment of digitalis intoxication was awakened 
with the report by Lown and associateszL 
that the amount of digitalis required to 
produce digitalis intoxication was related 
to the level of serum potassium. It was 
found that smaller doses of digitalis were 
required to produce intoxication when the 
serum potassium was low; and high levels 
of serum potassium had a protective effect 
in this regard. Prior studies by Loewi”’ 
in 1918, and Sampson and associates2” in 
1943, had reported that potassium was 
antagonistic to the toxic effects of digitalis, 
and that potassium was useful in the treat- 
ment of digitalis intoxication in man. 
EnselbergzA had observed that increased 
A-V block was a side effect of such po- 
tassium therapy. It soon became evident 
from other studies that potassium was not 
a specific antagonist of digitalis. For in- 
stance, it was found that potassium would 
abolish ectopic beats equally well in pa- 
tients who were receiving digitalis and in 
those who were not.25,26 It was also ob- 
served that, when A-V block was produced 
as the result of digitalis intoxication, ad- 
ministration of potassium did not release 
the block, but rather potentiated it.“7-30 
It was argued that potassium antagonism 
of digitalis was based on the rather non- 
specific depressing effect of potassium on 
ectopic rhythm. The conclusion to be 
reached from these studies is that the 
ability of potassium to suppress abnormal 
ectoplc rhythm is nonspecific but tran- 
siently effective whether or not such ab- 
normal rhythm is the result of digitalis 
intoxication. Potassium therapy is most 
useful when digitalis intoxication is the 
result of potassium depletion, for in this 
instance the therapeutic margin of safet) 
of digitalis is raised by returning the serum 
potassium to normal. Caution is advised 
in the use of potassium therapy when -4-V 
block is a manifestation of digitalis intoxi- 
cation, since under these circumstances 
digitalis and potassium are svnergistic. 
ProphyIactic use of potassimz with thiuzid~~ 
diurc~tics. The aggressive use of diuretic. 
agents, such as the thiazide and mercurial 
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types, initially increases the urinary excre- 
tion of potassium, as well as sodium, and 
may cause hypokalemia in some patients. 
Weller3r has presented the argument that 
the renal tubules of most patients and ex- 
perimental animals have the ability to 
counteract the loss of potassium which oc- 
curs in the initial phase of thiazide ad- 
ministration, and can correct any resulting 
negative balance of potassium in spite of 
the continued daily use of these drugs. 
Prolonged thiazide treatment may result 
in hypokalemia without significant de- 
pletion of the cellular stores of potassium. 
NO evidence is available that potassium 
therapy is beneficial in heart failure unless 
there is potassium depletion. As has been 
pointed out, a shift of potassium from the 
intracellular to the extracellular compart- 
ment in heart failure is caused by the use 
of large doses of digitalis, and possibly is 
an early effect of thiazide or other diuretic 
therapy. The data to date do not suggest 
that this shift is either beneficial or detri- 
mental, unless it reaches extreme propor- 
tions, in which case it may lead to digitalis 
intoxication. It is common knowledge that, 
when severe potassium depletion occurs 
after excessive diuresis, supplemental po- 
tassium is beneficial. Cort and Mathews32 
observed improvement in heart failure 
when a severe depletion of potassium was 
corrected. In this circumstance the finding 
of a low serum potassium, a reflection of 
the level of extracellular potassium, is the 
best guide of the need for supplemental 
potassium. When the need for supple- 
mental potassium arises, as indicated by 
an excessive diuresis, by low serum PO- 
tassium, or by the electrocardiographic 
changes of hypokalemia, the dose of po- 
tassium chloride required will generally 
be higher (such as 5 to 10 Gm. orally in 
divided doses) than the supplemental and 
routine dose now commonly prescribed 
(0.5 to 1 Gm. three times a day). ,4 normal 
diet generally contains 0.8 to 1.5 Gm. of 
potassium per 1,00033 calories and is the 
logical source of supply of potassium at 
other times. 
Potassium toxicity. The toxic effects of 
potassium are related to the concentration 
of potassium at the site of action, as well 
as to conditions such as oxygen deficit, 
increased concentration of hydrogen ion, 
and decreased concentration of sodium, 
which may alter the normal potassium 
equilibrium across cell membranes. When 
potassium is administered, the rate of ad- 
ministration becomes important, since this 
will reflect the peak concentration at the 
site of action. A slow intravenous infusion 
of potassium in experimental animals in- 
duces widespread block in all parts of the 
heart, associated with a reduction in pace- 
maker automaticity until death occurs by 
cardiac arrest.34 Rapid infusions are at- 
tended by increased automaticity through- 
out the heart, leading to ventricular pre- 
mature beats and ventricular fibrillation.“5 
Wiggers3” has demonstrated that ventricu- 
lar fibrillation of the dog’s heart can be 
promptly stopped by large doses of po- 
tassium. This paradoxical effect of the 
infusion of potassium may be explained if 
it is assumed that the raising of the con- 
centration of potassium to a moderately 
high level produces a condition of localized 
block throughout the heart which is favor- 
able for the production of ventricular 
fibrillation. If the infusion has been rapid 
enough so that pacemaker automaticity 
is temporarily enhanced at the same time 
that local blocks are produced, then ven- 
tricular fibrillation may be precipitated by 
a single ventricular beat, as suggested by 
Nahum and Hoff.35 If, on the other hand, 
the infusion is slow, the phase of increased 
automaticity is bypassed, and only de- 
pressed cardiac conduction and decreased 
pacemaker automaticity are encountered. 
The terminal event in this case is cardiac 
standstill. Still larger doses may slow con- 
duction sufficiently to arrest all cardiac 
activity, whether or not ventricular fibril- 
lation is present. The end result here is 
profound cardiac depression. 
Several reports of toxic effect in patients 
receiving potassium salts for digitalis in- 
toxication are of interest in that they point 
out the dangers of treating digitalis intoxi- 
cation with potassium when A-V block is 
one of the chief manifestations, and they 
also point out the fact that the oral use 
of potassium can be just as hazardous as 
the intravenous administration. According 
to two reports, potassium was used to 
treat digitalis intoxication manifest by 
complete heart block. In both instances, 
cardiac arrest resulted, leading to death 
4 Reynolds 
Am. Ncort 1. 
.711ly. 1965 
in one instance and resuscitation with 
molar sodium lactate in the other.37 Lown3* 
has commented on the dangers of treating 
digitalis intoxication in patients with 
heart failure, since hyperkalemia may re- 
sult. He reports on one such patient who 
received 5 Gm. of potassium chloride 
daily, and who developed atria1 standstill 
and intraventricular block with tall T 
waves, Saline infusions were effective in 
reversing this only while the infusion was 
running. The patient developed pulmonary 
edema and died with cardiac standstill. 
Fisch3!’ reports one case of transient cardiac 
arrest after the use of potassium for the 
treatment of paroxysmal atria1 tachy- 
cardia with block caused by digitalis. 
Fisch”O has also reported that the adminis- 
tration of potassium to a fully digitalized 
patient with atria1 fibrillation led to com- 
plete heart block. There have also been 
reports of serious shocklike symptoms after 
the oral administration of potassium salts 
to patients with kidney disease, and in 
patients receiving only 5 Gm. of potassium 
acetate orally who had no evidence of 
nitrogen retention.“3 
Conclusions 
It is apparent from the toxicity studies 
available that there is a high risk involved 
in potassium therapy in patients with 
renal disease, in patients with heart failure 
and digitalis intoxication when the serum 
potassium is normal, and in patients with 
high-grade A-V block. 
There is little evidence to suggest that 
potassium antagonizes any feature of digi- 
talis intoxication, other than digitalis- 
induced arrhythmias. Potassium therapy 
is of value in the disturbances in cardiac 
rhythm due to digitalis intoxication in 
cases in which A-V block is not the chief 
manifestation, and in certain disturbances 
in rhythm which are refractory to quinidine 
but which are not due to digitalis. Specif- 
ically, potassium is useful in the treatment 
of ventricular premature beats and ven- 
tricular tachycardia, but should be with- 
held in cases of atria1 fibrillation with high- 
grade A-V block and a regular ventricular 
rhythm. Its use in atria1 tachycardia with 
block has proved to be of value but carries 
additional risks because of the presence of 
block. It is contraindicated in the treat- 
ment of complete heart block caused by 
digitalis. 
The use of potassium in small daily sup- 
plementary doses to prevent the depletion 
of potassium in patients receiving digitalis 
and thiazides is unsound in most instances, 
and the routine use of potassium in this 
situation should be discontinued. Supple- 
mentary potassium may be helpful in the 
initial phase of diuresis in congestive heart 
failure and when the serum potassium is 
lower than normal. There should be no 
hesitancy about replacing potassium when 
there is hypokalemia, since most of the 
severe toxic effects associated with po- 
tassium therapy have occurred when it 
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